97225 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
ANTIGEN BINDING MOLECULES AND METHODS THEREOF I
#2B-CELL MATURATION ANTIGEN (BCMA) ANTI-IDIOTYPIC ANTIBODIES
#3ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE
#4PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF
#5ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR
#6Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor
#7PANCREATIC CANCER TARGETS AND USES THEREOF
#8ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS
#9Anti-pembrolizumab antibodies
#10ALTERING A B CELL PATHOLOGY USING SELF-DERIVED ANTIGENS IN CONJUNCTION WITH SPECIFIC-BINDING CYTOREDUCTIVE AGENT
#11PANCREATIC CANCER TARGETS AND USES THEREOF
#12Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)
#13Modified effector cell (or chimeric receptor) for treating disialoganglioside G-expressing neoplasia
#14Uses of monoclonial antibody 8H9
#15Therapeutic using a bispecific antibody
#16TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#17Pancreatic cancer targets and uses thereof
#18SPECIFIC BINDING PROTEINS AND USES THEREOF
#19SPECIFIC BINDING PROTEINS AND USES THEREOF
#20Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
#21SPECIFIC BINDING PROTEINS AND USES THEREOF
#22ANTI-IDIOTYPE ANTIBODIES OF THE HUMAN MONOCLONAL ANTIBODY SC-1, AND THEIR PRODUCTION AND USE
#23Uses of monoclonal antibody 8H9
#24IMMUNOGENIC, MONOCLONAL ANTIBODY
#25Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#26Uses of monoclonal antibody 8H9
#27Method for preparation of single chain antibodies
#28Immunological compositions as cancer biomarkers and/or therapeutics
#29TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#30Method for diagnosing efficacy of xenotypic antibody therapy
#31Pancreatic cancer targets and uses thereof
#32Combination therapy for treating disease
#33Anti-Lewis Y Anti-Idiotypic Antibodies and Uses Thereof
#34Therapeutic Compositions that alter the immune response
#35Therapeutic compositions that alter the immune response
#36Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
#37Method and composition for reconforming multi-epitopic antigens to intiate an immune response
#38Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
#39Targeted combination immunotherapy of cancer and infectious diseases
#40Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use
#41Therapeutic using a bispecific antibody
#42Peptides for stimulating an immune response against melanoma
#43Method and composition for reconforming multi-epitopic antigens to initiate an immune response
#44Method and composition for reconforming multi-epitopic antigens to initiate an immune response
#45Method for diagnosing efficacy of xenotypic antibody therapy
#46Method of cancer therapy by in situ production of F5 antibodies
#47Specific ab1'-antibodies against tumour-associated antigen ca 125
#48Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
#49Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
#50Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
#51Immunogenic monoclonal antibody
#52Uses of monoclonal antibody 8H9
#53Monoclonal antibodies and their use
#54Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
#55Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
#56Therapeutic binding agents against MUC-1 antigen and methods for their use
#57Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
#58Trans-membrane-antibody induced inhibition of apoptosis
#59Therapeutic compositions that alter the immune response